Adimai Technology is a provider of automated detection and separation and purification solutions, dedicated to the research, development, production and sales of clinical diagnostic application products based on molecular recognition technology-based automatic chromatography-mass spectrometry system detection technology. Adimai Technology recently announced that it has obtained strategic investment from Nanjing Innovation Investment Group. This round of financing will be mainly used for the rapid advancement of the company’s products and technologies. Adimai Technology announced the completion of angel round financing a few months ago, exclusively invested by Dynamic Balance Capital.
This article is transferred from: https://www.itjuzi.com/investevent/13760987
This site is only for collection, and the copyright belongs to the original author.